Literature DB >> 33794769

Advantages of imaging photoplethysmography for migraine modeling: new optical markers of trigemino-vascular activation in rats.

Alexey Y Sokolov1,2, Maxim A Volynsky3, Valery V Zaytsev3,4, Anastasiia V Osipchuk1, Alexei A Kamshilin5,6.   

Abstract

BACKGROUND: Existent animal models of migraine are not without drawbacks and limitations. The aim of our study was to evaluate imaging photoplethysmography (PPG) as a method of assessing intracranial blood flow in rats and its changes in response to electrical stimulation of dural trigeminal afferents.
METHODS: Experiments were carried out with 32 anesthetized adult male Wistar rats. Trigeminovascular system (TVS) was activated by means of electrical stimulation of dural afferents through a closed cranial window (CCW). Parameters of meningeal blood flow were monitored using a PPG imaging system under green illumination with synchronous recording of an electrocardiogram (ECG) and systemic arterial blood pressure (ABP). Two indicators related to blood-flow parameters were assessed: intrinsic optical signals (OIS) and the amplitude of pulsatile component (APC) of the PPG waveform. Moreover, we carried out pharmacological validation of these indicators by determining their sensitivity to anti-migraine drugs: valproic acid and sumatriptan. For statistical analysis the non-parametric tests with post-hoc Bonferroni correction was used.
RESULTS: Significant increase of both APC and OIS was observed due to CCW electrical stimulation. Compared to saline (n = 11), intravenous administration of both the sumatriptan (n = 11) and valproate (n = 10) by using a cumulative infusion regimen (three steps performed 30 min apart) lead to significant inhibitory effect on the APC response to the stimulation. In contrast, intravenous infusion of any substance or saline did not affect the OIS response to the stimulation. It was found that infusion of either sumatriptan or valproate did not affect the response of ABP or heart rate to the stimulation.
CONCLUSIONS: Imaging PPG can be used in an animal migraine model as a method for contactless assessment of intracranial blood flow. We have identified two new markers of TVS activation, one of which (APC) was pharmacologically confirmed to be associated with migraine. Monitoring of changes in APC caused by CCW electrical stimulation (controlling efficiency of stimulation by OIS) can be considered as a new way to assess the peripheral mechanism of action of anti-migraine interventions.

Entities:  

Keywords:  Animal model; Electrical stimulation; Imaging photoplethysmography; Intracranial blood flow; Migraine; Sumatriptan; Trigemino‐vascular system; Valproic acid

Mesh:

Substances:

Year:  2021        PMID: 33794769     DOI: 10.1186/s10194-021-01226-6

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  37 in total

Review 1.  Acute Treatment of Migraine.

Authors:  Stewart J Tepper
Journal:  Neurol Clin       Date:  2019-11       Impact factor: 3.806

Review 2.  Preventive Treatment for Episodic Migraine.

Authors:  Simy K Parikh; Stephen D Silberstein
Journal:  Neurol Clin       Date:  2019-08-22       Impact factor: 3.806

Review 3.  Migraine: Epidemiology, Burden, and Comorbidity.

Authors:  Rebecca C Burch; Dawn C Buse; Richard B Lipton
Journal:  Neurol Clin       Date:  2019-08-27       Impact factor: 3.806

Review 4.  Migraine: a brain state amenable to therapy.

Authors:  Michael Eller; Peter J Goadsby
Journal:  Med J Aust       Date:  2019-12-06       Impact factor: 7.738

5.  Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.

Authors:  Machaon Bonafede; Sandhya Sapra; Neel Shah; Stewart Tepper; Katherine Cappell; Pooja Desai
Journal:  Headache       Date:  2018-02-15       Impact factor: 5.887

Review 6.  Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.

Authors:  Simon Akerman; Philip R Holland; Jan Hoffmann
Journal:  Cephalalgia       Date:  2013-06       Impact factor: 6.292

Review 7.  Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans.

Authors:  Tessa de Vries; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Pharmacol Ther       Date:  2020-03-12       Impact factor: 12.310

8.  Burden and costs of migraine in a Swedish defined patient population - a questionnaire-based study.

Authors:  Frida Hjalte; Sara Olofsson; Ulf Persson; Mattias Linde
Journal:  J Headache Pain       Date:  2019-05-31       Impact factor: 7.277

Review 9.  Migraine and risk of stroke.

Authors:  Lise R Øie; Tobias Kurth; Sasha Gulati; David W Dodick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-26       Impact factor: 10.154

10.  Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.

Authors:  Ágnes Lublóy
Journal:  BMC Public Health       Date:  2019-09-09       Impact factor: 3.295

View more
  1 in total

1.  Study of cerebrovascular reactivity to hypercapnia by imaging photoplethysmography to develop a method for intraoperative assessment of the brain functional reserve.

Authors:  Maxim A Volynsky; Oleg V Mamontov; Anastasiia V Osipchuk; Valery V Zaytsev; Alexey Y Sokolov; Alexei A Kamshilin
Journal:  Biomed Opt Express       Date:  2021-12-07       Impact factor: 3.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.